A Unique Streptococcus Strain Now Dominates the Infection Landscape in the United Kingdom
By LabMedica International staff writers Posted on 04 Aug 2015 |
Image: Photomicrograph shows Streptococcus genotype emm89, which is typified by its lack of the hyaluronic acid capsule (Photo courtesy of Imperial College London).
British microbiologists have identified the mutations that were responsible for the dramatic increase in virulence of a Group A Streptococcus (GAS) variant that has now emerged as the dominant strain in the United Kingdom.
Investigators at Imperial College London (United Kingdom) used whole-genome sequencing techniques to analyze changes in the genome of GAS genotype emm89. A sharp rise in the number of infections caused by this particular strain was observed from 1998 to 2009.
Results of whole-genome sequencing revealed that although standard variable typing regions (emm subtype, tee type, sof type, and multilocus sequence typing [MLST]) remained unchanged, this unique subtype had undergone six distinct regions of homologous recombination across the genome compared to the rest of the sequenced emm89 population. Two of these regions affected known virulence factors, the hyaluronic acid capsule and the toxins NADase and streptolysin O.
Loss of the hyaluronic acid capsule was a particularly surprising finding, as it had been believed by microbiologists that the capsule was essential for GAS bacteria to cause invasive disease.
Senior author Dr. Shiranee Sriskandan, professor of medicine at Imperial College London, said, "This discovery was made possible thanks to the cooperation of our hospital diagnostic lab and the national reference lab, which helped us to spot a pattern locally and then study it nationally. We know very little about how group A Streptococcus is transmitted from person to person. We need to look into this more deeply and think about better ways to prevent transmission. Luckily, the new variant remains exquisitely sensitive to penicillin and related antibiotics. But we also need to think about whether our treatment strategies are as good as they can be."
The work was published in the July 14, 2015, online edition of the journal mBio.
Related Links:
Imperial College London
Investigators at Imperial College London (United Kingdom) used whole-genome sequencing techniques to analyze changes in the genome of GAS genotype emm89. A sharp rise in the number of infections caused by this particular strain was observed from 1998 to 2009.
Results of whole-genome sequencing revealed that although standard variable typing regions (emm subtype, tee type, sof type, and multilocus sequence typing [MLST]) remained unchanged, this unique subtype had undergone six distinct regions of homologous recombination across the genome compared to the rest of the sequenced emm89 population. Two of these regions affected known virulence factors, the hyaluronic acid capsule and the toxins NADase and streptolysin O.
Loss of the hyaluronic acid capsule was a particularly surprising finding, as it had been believed by microbiologists that the capsule was essential for GAS bacteria to cause invasive disease.
Senior author Dr. Shiranee Sriskandan, professor of medicine at Imperial College London, said, "This discovery was made possible thanks to the cooperation of our hospital diagnostic lab and the national reference lab, which helped us to spot a pattern locally and then study it nationally. We know very little about how group A Streptococcus is transmitted from person to person. We need to look into this more deeply and think about better ways to prevent transmission. Luckily, the new variant remains exquisitely sensitive to penicillin and related antibiotics. But we also need to think about whether our treatment strategies are as good as they can be."
The work was published in the July 14, 2015, online edition of the journal mBio.
Related Links:
Imperial College London
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia